136 related articles for article (PubMed ID: 451263)
1. [The therapeutic use of D-penicyllamine in the light of most recent pharmacokinetic and clinical observations (author's transl)].
Sarosiek J; Rudy J
Przegl Lek; 1979; 36(3):337-41. PubMed ID: 451263
[No Abstract] [Full Text] [Related]
2. [Therapeutic use of d-penicillamine].
Bogdanikowa B
Pol Tyg Lek; 1972 Oct; 27(41):1612-3. PubMed ID: 4581541
[No Abstract] [Full Text] [Related]
3. Inborn errors of copper metabolism: kinky hair disease and hepatolenticular degeneration. Therapeutic approaches.
Dekaban AS
Mater Med Pol; 1976; 8(2):167-72. PubMed ID: 979354
[No Abstract] [Full Text] [Related]
4. [Penicillamine in the treatment of scleroderma. Lathyrogenic drugs].
Szczepanski A
Przegl Dermatol; 1971; 58(3):355-9. PubMed ID: 4944035
[No Abstract] [Full Text] [Related]
5. The discovery of the therapeutic use of D-penicillamine.
Walshe JM
J Rheumatol Suppl; 1981; 7():3-8. PubMed ID: 7014875
[TBL] [Abstract][Full Text] [Related]
6. The metabolism and pharmacology of D-penicillamine in man.
Perrett D
J Rheumatol Suppl; 1981; 7():41-50. PubMed ID: 7014876
[TBL] [Abstract][Full Text] [Related]
7. Penicillamine.
Med Lett Drugs Ther; 1967 Jun; 9(13):51-2. PubMed ID: 6035365
[No Abstract] [Full Text] [Related]
8. [D-penicillamine].
Sternlieb I
Med Chir Dig; 1973; 2(1):1-2. PubMed ID: 4729529
[No Abstract] [Full Text] [Related]
9. [Current aspects of D-penicillamine and pregnancy].
Miehle W
Z Rheumatol; 1988; 47 Suppl 1():20-3. PubMed ID: 3063004
[TBL] [Abstract][Full Text] [Related]
10. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
Walshe JM
Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
[No Abstract] [Full Text] [Related]
11. [Effects and adverse effects of D-penicillamine].
Perings E; Junge U
Med Klin; 1975 Aug; 70(31):1265-74. PubMed ID: 1107780
[No Abstract] [Full Text] [Related]
12. Bio-inorganic effects of D-penicillamine in children and in the elderly.
Kean WF; Bellamy N; Lock CJ; Adachi J
Clin Invest Med; 1984; 7(1):77-83. PubMed ID: 6723129
[TBL] [Abstract][Full Text] [Related]
13. The copper-controlled diet: current aspects of dietary copper restriction in management of copper metabolism disorders.
Smithgall JM
J Am Diet Assoc; 1985 May; 85(5):609-10. PubMed ID: 3886765
[No Abstract] [Full Text] [Related]
14. [From gene to disease; Wilson disease: copper storage due to mutations in ATP7B].
Hoogenraad TU
Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1386-7. PubMed ID: 12892020
[No Abstract] [Full Text] [Related]
15. Copper toxicosis of the Bedlington terrier.
Sternlieb I
J Rheumatol Suppl; 1981; 7():94-5. PubMed ID: 6939891
[TBL] [Abstract][Full Text] [Related]
16. [D-Penacillamine. From constituent of penicillins to significant drug].
Lodemann E
Naturwissenschaften; 1979 Sep; 66(9):462-6. PubMed ID: 503243
[TBL] [Abstract][Full Text] [Related]
17. Decreased taste sensitivity after D-penicillamine reversed by copper administration.
Henkin RI; Keiser HR; Jafee IA; Sternlieb I; Scheinberg IH
Lancet; 1967 Dec; 2(7529):1268-71. PubMed ID: 4168610
[No Abstract] [Full Text] [Related]
18. [Hepatolenticular degeneration: biochemical and therapeutic considerations].
Clin Ter; 1976 Mar; 76(6):567-76. PubMed ID: 828082
[No Abstract] [Full Text] [Related]
19. [10 years of penicillamine].
Werner T; Weinmann HM
Med Klin; 1966 Nov; 61(46):1827-31. PubMed ID: 4231534
[No Abstract] [Full Text] [Related]
20. [An unusual cutaneous reaction pattern as a side effect of penicillamine: elastosis perforans serpiginosa].
van Joost T; de Leeuw J
Ned Tijdschr Geneeskd; 1988 Mar; 132(11):501-3. PubMed ID: 2965796
[No Abstract] [Full Text] [Related]
[Next] [New Search]
